We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alizyme | LSE:AZM | London | Ordinary Share | GB0000374289 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.08 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/6/2009 19:41 | Now gentlemen on the 24 th of this month i warned u- number 23706- that this company had a massive cash burn and had no money - i was slated . But who laughing now. | nathan2 | |
29/6/2009 15:58 | loaf. would appreciate any crumbs of comfort as this has been a complete disaster. First time I ever bought this was at issue and also went on the UC trial!! | joeblogg1000 | |
29/6/2009 15:57 | Dunder: he is being honest about the companies prospects. They are grim here, but he has to raise money and cut costs NOW. Its a virtual company. | silverbackalpha | |
29/6/2009 15:50 | loaf I will be trying what did he say - can take it offline if you like? | dunderheed | |
29/6/2009 15:41 | It is worth making the effort to call and talk to AG. Very helpful and open in his comments (within reason)and might help you step back from the edge so to speak. | loafofbread | |
29/6/2009 13:11 | From: Tim McCarthy [mailto:tim@alizyme. Sent: 15 December 2008 12:09 Subject: RE: Investor Update Thank you for your mails. My apologies for the delay in replying but I am travelling a great deal at the moment. Firstly, let me put your mind at rest about our cash position. As detailed in our recent Interim Management Statement, our overheads are now extremely low due to the completion of all clinical trials being conducted in-house by ourselves. This is together with a reduction in headcount as a result of the reduced activity. We have also received a $3 million milestone from Takeda recently which strengthened our cash position. As also detailed in the IMS, we are in continued discussions on partnering all the remaining rights in our portfolio, which of course includes the ROW rights to cetilistat. I trust this answers your concerns. Best regards Tim Dear Mr McCarthy, I enclose some of my recent emails, and look forward to hearing from you on these points. Right now I am very concerned about AZM running out of cash due to having high overheads. What are the overheads at the moment, and how much longer before the company collapses or goes bankrupt? The shares are 6p, and no deal as promised for the end of this year. I very much look forward to hearing from you at your earliest convenience, and I am genuinely concerned and worried about this company. Thanks. | silverbackalpha | |
29/6/2009 12:43 | Flibert: Understand this. An advisor has been "brought in", that is usually commissioned by a shareholder. It is usually a vulture to try and save the company at a desparate point. The management team are likely to be dismissed or got rid of. Tim is away on "holiday" hmmmmmmmmmmmmm. Litigation on misleading statements may be taken against him personally. The company WILL die if they do not raise money. Who will give them money??? THERE WILL BE MASSIVE DILUTION HERE in the best case scanario. More information, having faith in Tim. Wake up man. I am not telling you to sell, but give some thoguht to these facts. This company is pretty much finished as at today. | silverbackalpha | |
29/6/2009 12:42 | F3 - what are you on about - everything is fine and dandy this is a self financing virtual company model - don't you remember the Timiny going on about this?! Everythings okay he was stating this to another punter over on iii only a couple of weeks ago - this is just a communications issue and Timiny will land us the big deal he promised and we will be quids in - don't worry! | dunderheed | |
29/6/2009 12:41 | It was that long agon that they said AZM had enough money till next year, where has this money gone. what happened to financial plan B I am sure the financial institutions who put in £10 million a short while ago are fed up with being spun along and would like to know the truth for once about AZM! deals what deals who is interested who really isn't why aren't they interested?do any of the drugs have a future?!? | mole16 | |
29/6/2009 12:06 | Could go to 1/2p now IMO. Will just have to see. Up in the air right now. IF Tim can get booted out because of this it will be worth it for the good of private enterprise. | silverbackalpha | |
29/6/2009 11:39 | doctor. Surely you are not so blind or stupid as to think Tim actually lifted a finger for this company? In my view he "threw it". Take the cash, retire early. He could have pursued any number fo paths with cash in the bank and a 2-3 year time period. But he didnt. He just took took took. | silverbackalpha | |
29/6/2009 11:34 | Dunders - what are they supposed to do? Management have to be optimistic. A bit of research, thought or the comments from folk here would have shown the pros and cons of the products. Like I said, they were also unlucky in many respects. | the_doctor | |
29/6/2009 11:33 | B4 anyone hears it officially and all imho I am sure the arguement regarding funding is this - the Colal Pred requires more trial data/analysis - this is to be paid for (shared) out of the milestones that they were to receive - hence no cash - hence go 'private'? I personally think tim is already gone in everything but title! We as shareholders do need to understand why the FD was paid so much when he left and there are a few other CGT issues to be raised in the interim of course? | dunderheed | |
29/6/2009 11:22 | t_d - the behavior of this 'management' has been nothing short of scandalous - simple - the products are marginal - therefore the dressing up of these as clearly something they are not - by the 'management' is the true wrong here!! | dunderheed | |
29/6/2009 11:21 | Be under no illusion here. Tim has been bleeding this company. It is on its knees. I dont know who will give them any money. Plan A is to try desparately to get it. No money, no honey. Plan B is a firesale. Shareholders will think 2p is goo value in that scenario. | silverbackalpha | |
29/6/2009 11:15 | john henry - much of the disappointments have been due to the products, not the management. | the_doctor | |
29/6/2009 11:13 | That Tim is such a naughty boy! Technically silver he is on holiday - I assume he is on gardening leave? I will try and contact the real boss in the next few days - if that isn't too late!! | dunderheed | |
29/6/2009 11:13 | Another MMG, SKP, Aims littered with these disasters. Don't touch them with a barge pole imho. The incompetent Management in this sector has single handily destroyed investment into the UK bio-tech sector. | john henry | |
29/6/2009 10:48 | Peaeff: believe it or not I am and have been trying to help people. I have been trying to help people. I warned people of this company's pending bankruptcy a while ago. I write as I have nothing better to do, than observe and comment on such matters. I get pleasure from being right, thats all. | silverbackalpha | |
29/6/2009 10:46 | SB 1) why are you ringing AZM when you are not invested. What in gods name has it got to do with you. 2) If you are invested then why are you continually trying to make it look as though you are the saviour of manking and, why, when you held that view, did you get involved in the first place and not get out months ago. 3) your views, on this company, have been so diverse, since you arrived on this thread, that no-one has the slightest respect for any view you may express but, as your username suggest's, you are so thick skinned for that not to have sunk in. Why not leave these investors to their own courses of action and stop trying to be an 'I told you so' pr..k. Regards | peaeff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions